We are live on ! Find out more
ACM

Asymmetry Capital Management Portfolio holdings

AUM $188M
1-Year Est. Return 44.72%
This Fund
S&P 500
This Quarter Est. Return
-10.88%
1 Year Est. Return
+44.72%
3 Year Est. Return
+299.95%
5 Year Est. Return
+628.83%
10 Year Est. Return
–
AUM
$46.7M
AUM Growth
-$138M
Cap. Flow
-$128M
Cap. Flow %
-273.71%
Top 10 Hldgs %
69.4%
Holding
38
New
8
Increased
2
Reduced
12
Closed
16

Top Buys

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$3.6M
2
DXCM icon
DexCom
DXCM
+$2.3M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
+$1.84M
4
AMRN
Amarin Corp
AMRN
+$1.82M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$1.21M

Top Sells

Rank Stock Value
1
INGN icon
Inogen
INGN
+$12.8M
2
GBT
Global Blood Therapeutics, Inc.
GBT
+$12.5M
3
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$10.5M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$9.79M
5
INSM icon
Insmed
INSM
+$9.27M

Sector Composition

Rank Sector Weight
1 Healthcare 91.36%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVTR icon
26
Avantor
AVTR
$9.19B
– –
-122,962
Closed -$2.35M
CNC icon
27
Centene
CNC
$32.5B
– –
-147,638
Closed -$7.74M
ELV icon
28
Elevance Health
ELV
$85.5B
– –
-16,581
Closed -$4.68M
CBIO
29
Crescent Biopharma
CBIO
$626M
– –
-4,980
Closed -$5.94M
INGN icon
30
Inogen
INGN
$164M
– –
-191,970
Closed -$12.8M
IRTC icon
31
iRhythm Holdings
IRTC
$4.2B
– –
-14,854
Closed -$1.18M
JAZZ icon
32
Jazz Pharmaceuticals
JAZZ
$16.7B
– –
-63,940
Closed -$9.12M
OPK icon
33
Opko Health
OPK
$1.02B
– –
-1,628,666
Closed -$3.97M
PCRX icon
34
Pacira BioSciences
PCRX
$997M
– –
-84,735
Closed -$3.69M
SRPT icon
35
Sarepta Therapeutics
SRPT
$1.77B
– –
-11,050
Closed -$1.68M
UNH icon
36
UnitedHealth
UNH
$370B
– –
-30,767
Closed -$7.51M
VRAY
37
DELISTED
ViewRay, Inc.
VRAY
– –
-443,973
Closed -$3.91M
HMSY
38
DELISTED
HMS Holdings Corp.
HMSY
– –
-25,598
Closed -$829K
1
2

Similar funds

FAC
Forrestal Agricultural Corporation Princeton, New Jersey $183M AUM
SWM
Strategic Wealth Management Kirkland, Washington $202M AUM 9.35% 1-Year Est. Return
MC
MRJ Capital New York $173M AUM 31.99% 1-Year Est. Return
KM
Kylin Management New York $173M AUM 39.51% 1-Year Est. Return
TI
Truehand Inc Strafford, New Hampshire $171M AUM 25.9% 1-Year Est. Return
GC
Grace Capital Quincy, Massachusetts $168M AUM 21.6% 1-Year Est. Return
REMS
Real Estate Management Services $167M AUM 37.69% 1-Year Est. Return
NM
Nokota Management New York $165M AUM

Asymmetry Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Asymmetry Capital Management held 38 positions worth $46.7M, down 75% from $185M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Asymmetry Capital Management withdrew a net $128M in Q3 2019, closing 16 positions and reducing 12 holdings. Its most notable exit was Inogen, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 90% a quarter earlier, followed by Industrials.

Against the trend, Asymmetry Capital Management opened a new position in GW Pharmaceuticals Plc American Depositary Shares worth $2.73M.

  • Asymmetry Capital Management's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 23,729 shares worth $2.73M.
  • Asymmetry Capital Management added most to Antares Pharma, Inc. in Q3 2019, an estimated $336K increase.
  • Asymmetry Capital Management's biggest Q3 2019 reduction was Global Blood Therapeutics, Inc., cutting an estimated $12.5M.
  • Asymmetry Capital Management fully exited Inogen in Q3 2019, selling an estimated $12.8M.
  • Asymmetry Capital Management's ten largest holdings make up 69% of its $46.7M portfolio in Q3 2019.
  • Asymmetry Capital Management opened 8 new positions and closed 16 in Q3 2019.
  • Asymmetry Capital Management's portfolio value fell 75% quarter-over-quarter to $46.7M.

Based on Asymmetry Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.